Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
10/05/2000 | WO2000058453A2 Plants transformed with thioredoxin |
10/05/2000 | WO2000058449A1 Hydantoinase variants with improved properties and their use for the production of amino acids |
10/05/2000 | WO2000058446A1 HUMAN PROTEIN KINASE Bη POLYPEPTIDES AND A METHOD FOR DISRUPTING PROTEIN KINASE Bη IN A NON-HUMAN |
10/05/2000 | WO2000058445A1 Polypeptides having branching enzyme activity and nucleic acids encoding same |
10/05/2000 | WO2000058443A1 Method for selectively separating blood cells by using lectin |
10/05/2000 | WO2000058364A1 Antibodies to placental protein 13 |
10/05/2000 | WO2000058363A1 Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases |
10/05/2000 | WO2000058359A1 Retro-inverso prosaposin-derived peptides and use thereof |
10/05/2000 | WO2000058358A1 49 human secreted proteins |
10/05/2000 | WO2000058357A1 50 human secreted proteins |
10/05/2000 | WO2000058356A1 50 human secreted proteins |
10/05/2000 | WO2000058355A1 50 human secreted proteins |
10/05/2000 | WO2000058353A1 Npcahh01: human transmembrane protein e3-16 gene |
10/05/2000 | WO2000058352A2 Barley gene for thioredoxin and nadp-thioredoxin reductase |
10/05/2000 | WO2000058350A1 49 human secreted proteins |
10/05/2000 | WO2000058342A1 Process for partitioning of proteins |
10/05/2000 | WO2000058340A2 50 human secreted proteins |
10/05/2000 | WO2000058339A2 50 human secreted proteins |
10/05/2000 | WO2000058336A1 50 human secreted proteins |
10/05/2000 | WO2000058335A1 47 human secreted proteins |
10/05/2000 | WO2000058334A1 50 human secreted proteins |
10/05/2000 | WO2000057922A1 Intramyocardial injection of autologous bone marrow |
10/05/2000 | WO2000057920A2 Method for expressing proteins |
10/05/2000 | WO2000057903A2 48 human secreted proteins |
10/05/2000 | WO2000057891A1 Compositions and methods for producing platelets and/or proplatelets from megakaryocytes |
10/05/2000 | WO2000057861A2 Use of cytidine derivatives for the treatment of leukaemia |
10/05/2000 | WO2000057705A1 In vitro induction of antigen-specific t-cells using dendritic cell-tumor cell or dendritic cell-viral cell derived immunogens |
10/05/2000 | WO2000032788A3 Method for regulating carotenoid biosynthesis in marigolds |
10/05/2000 | WO2000031280A3 Use of plus-strand synthesis elements in retroviral vectors |
10/05/2000 | WO2000031258A3 Human orphan g protein-coupled receptors |
10/05/2000 | WO2000031133A3 Potassium channel interactors and uses therefor |
10/05/2000 | WO2000031127A3 Protein fragments for use in protein targeting |
10/05/2000 | WO2000029574A3 Inflammation-associated genes |
10/05/2000 | WO2000029002A3 In utero transplantation of human mesenchymal stem cells |
10/05/2000 | WO2000028060A3 Cells for the production of helper dependent adenoviral vectors |
10/05/2000 | WO2000028043A3 Polypeptides having lactonohydrolase activity and nucleic acids encoding same |
10/05/2000 | WO2000028039A3 Identification of senv genotypes |
10/05/2000 | WO2000026379A3 Polypeptide mediating cell permeability |
10/05/2000 | WO2000026246A3 Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof |
10/05/2000 | WO2000026243A3 Transmembrane 4 proteins |
10/05/2000 | WO2000022130A3 Metastatic breast and colon cancer regulated genes |
10/05/2000 | WO2000012736A3 A new method of identifying non-host plant disease resistance genes |
10/05/2000 | WO2000011176A3 Genes for plant fatty acid modifying enzymes associated with conjugated double bond formation |
10/05/2000 | WO2000011167A3 Nucleic acids encoding a functional human purinoreceptor p2x2 and methods of producing and use thereof |
10/05/2000 | WO2000001716A3 Vasculoprotector |
10/05/2000 | DE19920004C1 New cellular regulation factor TTO 20, useful for identifying specific modulators and producing antibodies for diagnosis of rheumatoid arthritis |
10/05/2000 | DE19915178A1 Hepatitis C Virus Zellkultursystem Hepatitis C virus cell culture system |
10/05/2000 | CA2383592A1 2384891 acids including open reading frames encoding polypeptides; orfx |
10/05/2000 | CA2370441A1 50 human secreted proteins |
10/05/2000 | CA2369458A1 47 human secreted proteins |
10/05/2000 | CA2368998A1 Delivery of functional protein sequences by translocating polypeptides |
10/05/2000 | CA2368951A1 50 human secreted proteins |
10/05/2000 | CA2368927A1 45 human secreted proteins |
10/05/2000 | CA2368909A1 48 human secreted proteins |
10/05/2000 | CA2368881A1 50 human secreted proteins |
10/05/2000 | CA2368854A1 Barley gene for thioredoxin and nadp-thioredoxin reductase |
10/05/2000 | CA2368835A1 Insect viral vectors and uses thereof |
10/05/2000 | CA2368760A1 Flint polypeptide analogs |
10/05/2000 | CA2368744A1 Value-added traits in grain and seed transformed with thioredoxin |
10/05/2000 | CA2368719A1 50 human secreted proteins |
10/05/2000 | CA2368700A1 49 human secreted proteins |
10/05/2000 | CA2368489A1 50 human secreted proteins |
10/05/2000 | CA2368482A1 50 human secreted proteins |
10/05/2000 | CA2368477A1 Polynucleotide and deduced amino acid sequences from stromal cells |
10/05/2000 | CA2368469A1 50 human secreted proteins |
10/05/2000 | CA2368467A1 50 human secreted proteins |
10/05/2000 | CA2368442A1 48 human secreted proteins |
10/05/2000 | CA2368379A1 Human protein kinase b.gamma. polypeptides and a method for disrupting protein kinase b.gamma. in a non-human |
10/05/2000 | CA2368376A1 50 human secreted proteins |
10/05/2000 | CA2368374A1 47 human secreted proteins |
10/05/2000 | CA2368302A1 49 human secreted proteins |
10/05/2000 | CA2368281A1 50 human secreted proteins |
10/05/2000 | CA2368119A1 Chimeric expression promoters originating from commelina yellow mottle virus and cassava vein mosaic virus |
10/05/2000 | CA2368040A1 Ku80 homolog and uses thereof |
10/05/2000 | CA2368014A1 Casb619 involved in colon cancers |
10/05/2000 | CA2367999A1 Polypeptides having branching enzyme activity and nucleic acids encoding same |
10/05/2000 | CA2367901A1 Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases |
10/05/2000 | CA2367826A1 Process for partitioning of proteins |
10/05/2000 | CA2367766A1 Retro-inverso prosaposin-derived peptides and use thereof |
10/05/2000 | CA2367761A1 Antibodies to placental protein 13 |
10/05/2000 | CA2366305A1 Method for expressing proteins |
10/05/2000 | CA2366012A1 Methods of treating leukemia |
10/05/2000 | CA2365601A1 Novel cytidine deaminase |
10/05/2000 | CA2365596A1 Compositions and methods for the modification of gene expression |
10/05/2000 | CA2365297A1 Methods for the identification and validation of functional intracellular targets with intramers or in vivo selection |
10/05/2000 | CA2364305A1 Isolated dna encoding cullin regulators roc1 and roc2, isolated proteins encoded by the same, and methods utilizing the same |
10/05/2000 | CA2363716A1 49 human secreted proteins |
10/05/2000 | CA2361408A1 Schizophrenia associated genes, proteins and biallelic markers |
10/04/2000 | EP1041152A1 Retroviral vectors |
10/04/2000 | EP1041148A1 Pathogen inducible promoter |
10/04/2000 | EP1041144A1 Methods for the identification and validation of functional intracellular targets with intramers or in vivo selection |
10/04/2000 | EP1041143A2 A method for identification of biologically active peptides and nucleic acids |
10/04/2000 | EP1041142A2 Universal donor cells |
10/04/2000 | EP1040196A2 Transgenic animal model for degenerative diseases of cartilage |
10/04/2000 | EP1040195A2 Regulatory dna sequences of the human catalytic telomerase sub-unit gene, diagnostic and therapeutic use thereof |
10/04/2000 | EP1040194A1 Human signal transduction serine/threonine kinase |
10/04/2000 | EP1040193A1 Promoter from ashbya gossypii |
10/04/2000 | EP1040191A2 Rantes mutants and therapeutic applications thereof |
10/04/2000 | EP1040187A2 Human protein kinase and kinase inhibitors |
10/04/2000 | EP1040185A2 Neural precursor cells, method for the production and use thereof in neural defect therapy |